DrugDashboards

Market view

quinapril and hydrochlorothiazide · Tablet

3 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now.

What changed in the last 90 days

Every detected change for quinapril and hydrochlorothiazide, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Angiotensin Converting Enzyme Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Quinapril and hydrochlorothiazide in shortage right now?
Yes. FDA currently lists Quinapril and hydrochlorothiazide in shortage. This page is rebuilt every morning from FDA's shortage database.
Who makes Quinapril and hydrochlorothiazide?
1 company has marketed Quinapril and hydrochlorothiazide in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

  • In shortage now — Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90)Jan 19, 2023
  • In shortage now — Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90)Jan 19, 2023
  • In shortage now — Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90)Jan 19, 2023

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.